Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis

BACKGROUND: We estimated COVID-19 vaccine effectiveness against SARS-CoV-2 infection and severe COVID-19 outcomes among individuals with immune-mediated inflammatory diseases in Ontario, Canada. METHODS: In this population-based analysis, we used a test-negative design across four immune-mediated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Widdifield, Jessica, Kwong, Jeffrey C, Chen, Simon, Eder, Lihi, Benchimol, Eric I, Kaplan, Gilaad G, Hitchon, Carol, Aviña-Zubieta, J Antonio, Lacaille, Diane, Chung, Hannah, Bernatsky, Sasha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009845/
https://www.ncbi.nlm.nih.gov/pubmed/35441151
http://dx.doi.org/10.1016/S2665-9913(22)00096-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009845/
https://www.ncbi.nlm.nih.gov/pubmed/35441151
http://dx.doi.org/10.1016/S2665-9913(22)00096-0

Ejemplares similares